Skip to content

Effects of Vitamin D Supplementation on Postoperative Rehabilitation in Hip and Knee Osteoarthritis Patients

Effects of Vitamin D Supplementation on Postoperative Rehabilitation in Hip and Knee Osteoarthritis Patients: a Multicenter Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06747559
Enrollment
300
Registered
2024-12-24
Start date
2025-01-01
Completion date
2026-12-31
Last updated
2024-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Arthroplasty, Osteoarthritis of the Hip or Knee

Brief summary

The goal of this clinical trial is to learn if vitamin D supplementation affects postoperative rehabilitation in osteoarthritis patients who underwent joint arthroplasty. The main questions it aims to answer are: Does oral vitamin D supplementation for a period of time after joint arthroplasty affect the postoperative recovery speed in patients who have vitamin D deficiency? Does oral vitamin D supplementation after joint arthroplasty affect the long-term recovery of joint functions in patients who have vitamin D deficiency? Participants will: Take vitamin D oral supplement every day for 3 months. Visit the clinic in 1, 3, 6, 12 months after joint replacement surgery for checkups and tests.

Interventions

DRUGVitamin D

Vitamin D oral supplementation

Sponsors

Yiwu Fuyuan Private Hospital
CollaboratorUNKNOWN
Hangzhou Xiaoshan Traditional Chinese Orthopedic Hospital
CollaboratorUNKNOWN
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Vitamin D deficiency (blood 25-hydroxyvitamin D value \< 20ng/ml); 2. Meeting the diagnostic criteria for hip or knee osteoarthritis; 3. Planning to undergo hip or knee arthroplasty after clinical assessment;

Exclusion criteria

1\. Having other diseases that could cause damage to the bone or cartilage structure of the hip or knee, such as trauma, joint infection, congenital joint malformation, and systemic diseases such as rheumatoid arthritis and gout.

Design outcomes

Primary

MeasureTime frameDescription
Knee joint functionFrom enrollment to the end of treatment at 1 yearWestern Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Pain ranging from 0 to 20 points; stiffness, 0 to 8 points; and physical function, 0 to 68 points. Higher scores represent worse pain, stiffness, and functional limitations.
Hip joint functionFrom enrollment to the end of treatment at 1 yearHarris Hip Score. The maximum score possible is 100. Results can be interpreted with the following: \<70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.
Muscle strengthFrom enrollment to the end of treatment at 1 yearUsing portable muscle strength tester to measure flexor and extensor muscle strength of knee or hip joint

Countries

China

Contacts

Primary ContactXiang Zhao, MD
flyingzhao@zju.edu.cn8613750835297
Backup ContactZihao Qu, MD
qu_z.h@zju.edu.cn8615700079560

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026